According to

Real-world
claims data

86

%

OF VILTEPSO
PATIENTS*

Remained
on treatment

after 12 months1

*In an eligible cohort

Reference: 1. Data on File.
NS Pharma, Inc.; 2025.

© 2025 NS Pharma, Inc.
All rights reserved. NS Pharma and the symbol for NS Pharma are registered trademarks of Nippon Shinyaku Co., Ltd. Viltepso is a registered trademark of Nippon Shinyaku Co., Ltd.

10/25 US-NS65C-1808